Gilead Sciences (NASDAQ:GILD) to Present at Upcoming Investor Conferences

November 4, 2025 — Leads & Copy —

FOSTER CITY, Calif. — Gilead Sciences, Inc. (Nasdaq: GILD) will have executives speaking at several upcoming investor conferences, including the UBS Global Healthcare Conference on November 10, the Jefferies Global Healthcare Conference in London on November 19, Citi’s Global Healthcare Conference on December 2, and the Annual Evercore Healthcare Conference on December 3.

Live webcasts of the presentations will be available on the company’s investor relations page.

Gilead Sciences, Inc. is a biopharmaceutical company committed to advancing innovative medicines to prevent and treat life-threatening diseases.

For more information, visit the company’s website or follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Source: Gilead Sciences, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.